Inhibition of highly pathogenic PRRSV replication in MARC-145 cells by artificial microRNAs

Virology Journal

Volumn 8, Issue , 2011, Pages

  Xiao, Shuqi ^a,b   Wang, Qiwei ^a,b   Gao, Jintao ^a,b   Wang, Liangliang ^a,b   He, Zuyong ^a,b   Mo, Delin ^a,b   Liu, Xiaohong ^a,b   Chen, Yaosheng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Pig Improving and Breeding Project Technology   (China)

Author keywords

artificial miRNA; Highly pathogenic PRRSV; Lentivirus; RNAi

Indexed keywords

ARTIFICIAL MICRORNA GP5 243; ARTIFICIAL MICRORNA GP5 370; ARTIFICIAL MICRORNA M 217; ARTIFICIAL MICRORNA M 263; ARTIFICIAL MICRORNA M 82; INTERFERON; MICRORNA; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT;

ANIMAL CELL; ARTERIVIRUS; ARTICLE; GENETIC TRANSFECTION; HAPLORHINI; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; CERCOPITHECUS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING;

LENTIVIRUS; MURINAE; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; MICRORNAS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; VIRUS REPLICATION;

EID: 80055048135     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-491     Document Type: Article

References (43)

1. Understanding PRRSV infection in porcine lung based on genome-wide transcriptome response identified by deep sequencing. Xiao S, Jia J, Mo D, Wang Q, Qin L, He Z, Zhao X, Huang Y, Li A, Yu J, et al. PLoS One 2010 5 11377 10.1371/journal.pone.0011377 20614006
2. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ, J Am Vet Med Assoc 2005 227 385 392 10.2460/javma.2005.227.385 16121604 (Pubitemid 41098522)
3. Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Meulenberg JJ, Hulst MM, de Meijer EJ, Moonen PL, den Besten A, de Kluyver EP, Wensvoort G, Moormann RJ, Virology 1993 192 62 72 10.1006/viro.1993.1008 8517032
4. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Dea S, Gagnon CA, Mardassi H, Pirzadeh B, Rogan D, Archives of virology 2000 145 659 688 10.1007/s007050050662 10893147 (Pubitemid 30306142)
5. Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Delputte PL, Meerts P, Costers S, Nauwynck HJ, Vet Immunol Immunopathol 2004 102 179 188 10.1016/j.vetimm.2004.09.007 15507304 (Pubitemid 39422643)
6. Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity. Snijder EJ, Dobbe JC, Spaan WJ, Journal of virology 2003 77 97 104 10.1128/JVI.77.1.97-104.2003 12477814 (Pubitemid 36004950)
7. Characterization of regions in the GP5 protein of porcine reproductive and respiratory syndrome virus required to induce apoptotic cell death. Fernandez A, Suarez P, Castro JM, Tabares E, Diaz-Guerra M, Virus Res 2002 83 103 118 10.1016/S0168-1702(01)00426-9 11864744 (Pubitemid 34183379)
8. Chimeric arteriviruses generated by swapping of the M protein ectodomain rule out a role of this domain in viral targeting. Verheije MH, Welting TJ, Jansen HT, Rottier PJ, Meulenberg JJ, Virology 2002 303 364 373 10.1006/viro.2002.1711 12490397 (Pubitemid 36069199)
9. Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages. Delputte PL, Vanderheijden N, Nauwynck HJ, Pensaert MB, J Virol 2002 76 4312 4320 10.1128/JVI.76.9.4312-4320.2002 11932397 (Pubitemid 34309567)
10. The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner. Van Breedam W, Van Gorp H, Zhang JQ, Crocker PR, Delputte PL, Nauwynck HJ, PLoS pathogens 2010 6 1000730 10.1371/journal.ppat.1000730 20084110
11. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. Tian K, Yu X, Zhao T, Feng Y, Cao Z, Wang C, Hu Y, Chen X, Hu D, Tian X, et al. PLoS ONE 2007 2 526 10.1371/journal.pone.0000526 17565379
12. Aberrant host immune response induced by highly virulent PRRSV identified by digital gene expression tag profiling. Xiao S, Mo D, Wang Q, Jia J, Qin L, Yu X, Niu Y, Zhao X, Liu X, Chen Y, BMC Genomics 2010 11 544 10.1186/1471-2164-11-544 20929578
13. Suppression of gene expression by homologous transgenes. Cogoni C, Romano N, Macino G, Antonie van Leeuwenhoek 1994 65 205 209 10.1007/BF00871948 7847887 (Pubitemid 24276035)
14. Molecular biology. Sharp PA, Zamore PD, RNA interference. Science (New York, NY) 2000 287 2431 2433
15. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J, Proceedings of the National Academy of Sciences of the United States of America 2003 100 2718 2723 10.1073/pnas.0437841100 12594334 (Pubitemid 36297565)
16. Interference of hepatitis A virus replication by small interfering RNAs. Kanda T, Kusov Y, Yokosuka O, Gauss-Muller V, Biochemical and biophysical research communications 2004 318 341 345 10.1016/j.bbrc.2004.03.194 15120607 (Pubitemid 38553786)
17. Persistence of porcine reproductive and respiratory syndrome virus in serum and semen of adult boars. Christopher-Hennings J, Nelson EA, Hines RJ, Nelson JK, Swenson SL, Zimmerman JJ, Chase CL, Yaeger MJ, Benfield DA, J Vet Diagn Invest 1995 7 456 464 10.1177/104063879500700406 8580165
18. Lentivirus-delivered stable gene silencing by RNAi in primary cells. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, et al. RNA (New York, NY) 2003 9 493 501 (Pubitemid 36356735)
19. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, et al. Nature genetics 2003 33 401 406 10.1038/ng1117 12590264 (Pubitemid 36278858)
20. Subramanya S, Shankar P: Lentiviral delivery of short hairpin RNAs. Manjunath N, Wu H, Advanced drug delivery reviews 2009 61 732 745 10.1016/j.addr.2009.03.004 19341774
21. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Liu YP, Haasnoot J, ter Brake O, Berkhout B, Konstantinova P, Nucleic acids research 2008 36 2811 2824 10.1093/nar/gkn109 18346971 (Pubitemid 351737175)
22. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B, Nucleic acids research 2004 32 1154 1158 10.1093/nar/gkh278 14966264 (Pubitemid 38854717)
23. Artificial microRNA-mediated virus resistance in plants. Qu J, Ye J, Fang R, Journal of virology 2007 81 6690 6699 10.1128/JVI.02457-06 17344304 (Pubitemid 46878073)
24. Second-generation shRNA libraries covering the mouse and human genomes. Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR, et al. Nature genetics 2005 37 1281 1288 16200065 (Pubitemid 41568714)
25. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Liu YP, von Eije KJ, Schopman NC, Westerink JT, ter Brake O, Haasnoot J, Berkhout B, Mol Ther 2009 17 1712 1723 10.1038/mt.2009.176 19672247
26. Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Daly C, Reich NC, Molecular and cellular biology 1993 13 3756 3764 8388546 (Pubitemid 23157312)
27. Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation. Kenworthy R, Lambert D, Yang F, Wang N, Chen Z, Zhu H, Zhu F, Liu C, Li K, Tang H, Nucleic acids research 2009 37 6587 6599 10.1093/nar/gkp714 19729514
28. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Kimman TG, Cornelissen LA, Moormann RJ, Rebel JM, Stockhofe-Zurwieden N, Vaccine 2009 27 3704 3718 10.1016/j.vaccine.2009.04.022 19464553
29. Inhibition of porcine reproductive and respiratory syndrome virus replication by short hairpin RNA in MARC-145 cells. Huang J, Jiang P, Li Y, Xu J, Jiang W, Wang X, Vet Microbiol 2006 115 302 310 10.1016/j.vetmic.2006.02.018 16584853
30. Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs. He YX, Hua RH, Zhou YJ, Qiu HJ, Tong GZ, Antiviral Res 2007 74 83 91 10.1016/j.antiviral. 2006.04.013 16730075 (Pubitemid 46436164)
31. Suppression of porcine reproductive and respiratory syndrome virus replication in MARC-145 cells by shRNA targeting ORF1 region. Li G, Huang J, Jiang P, Li Y, Jiang W, Wang X, Virus Genes 2007 35 673 679 10.1007/s11262-007- 0134-8 17671836 (Pubitemid 350012768)
32. Effective suppression of replication of porcine reproductive and respiratory syndrome virus by adenovirus-mediated small interfering RNAs targeting ORF1b, 5 and 7 genes. Li G, Jiang P, Li Y, Wang X, Huang J, Du Y, Zeshan B, J Virol Methods 2009 157 40 46 10.1016/j.jviromet.2008.12.001 19118577
33. Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine. Li G, Jiang P, Li Y, Wang X, Huang J, Bai J, Cao J, Wu B, Chen N, Zeshan B, Antiviral research 2009 82 157 165 10.1016/j.antiviral.2009. 02.202 19428607
34. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. Chen W, Liu M, Jiao Y, Yan W, Wei X, Chen J, Fei L, Liu Y, Zuo X, Yang F, et al. J Virol 2006 80 3559 3566 10.1128/JVI.80.7.3559-3566.2006 16537624
35. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P, Mol Ther 2006 13 411 421 10.1016/j.ymthe.2005.10.013 16337206 (Pubitemid 43056907)
36. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
37. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA, Nature 2006 441 537 541 10.1038/nature04791 16724069 (Pubitemid 44050158)
38. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Giering JC, Grimm D, Storm TA, Kay MA, Mol Ther 2008 16 1630 1636 10.1038/mt.2008.144 18665161
39. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? Grimm D, Kay MA, The Journal of clinical investigation 2007 117 3633 3641 10.1172/JCI34129 18060021 (Pubitemid 350224069)
40. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development. Rao DD, Senzer N, Cleary MA, Nemunaitis J, Cancer gene therapy 2009 16 807 809 10.1038/cgt.2009.53 19713999
41. Tuning silence: conditional systems for RNA interference. Wiznerowicz M, Szulc J, Trono D, Nature methods 2006 3 682 688 10.1038/nmeth914 16929312 (Pubitemid 44275734)
42. Proteome changes of lungs artificially infected with H-PRRSV and N-PRRSV by two-dimensional fluorescence difference gel electrophoresis. Xiao S, Wang Q, Jia J, Cong P, Mo D, Yu X, Qin L, Li A, Niu Y, Zhu K, et al. Virol J 2010 7 107 10.1186/1743-422X-7-107 20504321
43. Design of extended short hairpin RNAs for HIV-1 inhibition. Liu YP, Haasnoot J, Berkhout B, Nucleic acids research 2007 35 5683 5693 10.1093/nar/gkm596 17715143 (Pubitemid 47506286)